Trivis Co., Ltd. (CEO Moo-yeol Cho) participated in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Established in 2002, Trivis is a company that has supplied skin care medical devices and cosmetics, focusing on dermatology and plastic surgery. Afterwards, starting with the import of magnetic field hair loss treatment medical equipment ‘ETG Mark2008’ from Canada in 1, the product line was expanded to include hair loss treatment devices, and the same product was developed and manufactured locally as ‘H-cell ST’ in 2012. I’m doing it. The company explains that this is used in many domestic hair loss hospitals and is contributing to increasing treatment effectiveness and improving marketing competitiveness.
At this exhibition, Trivis introduced the ‘H-cell ST’ series, a model that is a domestically produced model of ‘ETG Mark1’. This is a product line currently branded as ‘Haircell S2’ in Korea, and it exerts a therapeutic effect by irradiating the scalp for 12 minutes once or twice a week.
Haircell S2 aims to stimulate cells involved in hair production by generating a micromagnetic field of a special waveform during treatment. Trivis stated that this helps the cells recover their original function regardless of the cause of hair loss, and the effect was found to reach a hair loss treatment rate of 96.7% and a hair loss rate of 66.1%. In addition, Haircell S2 treatment can be combined with other hair loss treatments, making it a solution that can maximize the overall treatment effect.
A Trivis official said, “Among the various products that have been released on the market under the Haircell S2 brand, we expect that the new product ‘Haircell Mark1’ will show better effects by combining micromagnetic field energy with light irradiation functions such as laser and LED.” “Noting that the new product is popular not only in hospitals specializing in hair loss treatment and treatment, but also in dermatology and plastic surgery, we designed it so that it can be connected to a mask-type skin irradiator instead of the existing helmet-type scalp irradiator, so it has greater versatility.” It was elaborate.
He continued, “Haircell S2 is well-received domestically in terms of its therapeutic effects and marketing, but due to the limited market size, we are looking for sales channels overseas as well.” He added, “In fact, several overseas buyers have inquired about the possibility of exporting. “We will use this exhibition as an opportunity to secure and expand our influence in the global market,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
In KIMES 2023, new technologies and products suitable for the era of convergence, such as smart healthcare in the era of the 4th industrial revolution, robot medical care and eco-friendly medical waste facilities, advanced hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation, will be presented. showed off In addition, various information was provided, including seminars on medical technology, new technologies, and overseas marketing, as well as domestic medical industry policy seminars to show the latest information and the direction of the medical industry.
→ Go to KIMES 2023 news special page
